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Conclusions.  (1) Aging is a set of processes, each reducing the body's resistance. (2) 
Understanding the aging process, however, can provide us with different solutions to slow 
down the process and enjoy health and vitality for a longer time.  
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Introduction.  Gastroesophageal reflux disease is a common clinical pathology of the upper 
digestive tract, due to the reflux of the gastric or duodenal content within the esophagus, caused 
by a failure of the antireflux mechanisms, namely the lower esophageal sphincter.   
Aim of the study.  To study the clinical features, the diagnostic methods and the therapeutic 
treatment in patients with gastroesophageal reflux disease   
Materials and methods.  The retrospective study was conducted on 120 patients, admitted at 
the Department of Gastroenterology, within "Timofei Moșneaga" Republican Clinical 
Hospital. The study included two groups of patients: 60 patients, hospitalized during 2017-
2018 years and 60 patients admitted during 2018-2019, aged between 18- 80 years old. The 
data regarding the patients’ complaints, anamnesis, methods of diagnosis and treatment 
outcomes have been studied and interpreted.   
Results.  The study showed a higher incidence of female patients in both study groups. 
According to the age criterion, 33.33% of patients were aged between 51 -70 years old and 
only 1.66% - aged under 20. The most common patients ‘complaints (more than 50%) included 
as following: 85.8% of cases presented epigastric pain, 53.3% - belching and 52.5%- heartburn 
, followed by 48.3%- mouth bitterness, 44.1 % - nausea and 30.8% -bloating. The least recorded 
complaints were regurgitations in 5% of cases and dysphagia - 4.1%. Both groups of patients 
were diagnosed based on the presence of the classic symptoms of GERD, positive response to 
PPI treatment, upper digestive endoscopy and chest X-ray assessment. According to the study, 
during the period 2017 -2018, the treatment of patients with GERD was mainly aimed at 
reducing the gastric acid secretion by administering omeprazole - 71.7% and pantoprazole - 
18.4%. In 2018-2019 years, patients with GERD underwent a treatment for increasing the 
intestinal motility, by administrating metoclopramide - 68.4%, followed by the proton pump 
inhibitors -pantoprazole - 30%, omeprazole - 21.7% and antacids - 28.4%.   
Conclusions.  The study of the gastroesophageal reflux disease particularities in patients from 
the Department of Gastroenterology has proved that the diagnosis should be based on the 
presence of the classic symptoms, changes detected in the upper digestive endoscopy and the 
presence of the reflux on the chest X-Ray assessment. The treatment regimens included both 
the suppression of gastric acidic secretion and the increase of the intestinal motility, thus 
diminishing the action of the harmful factors on LES and esophageal mucosa.   
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